Find clinical trials for Breast Cancer in Austin, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Austin, TX, USA:
kinesin oral molecular degrader, administered as monotherapy or in combination with fulvestrant in adults with advanced or metastatic breast ...
Phase 1
Austin, Texas, United States and 4 other locations
standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...
Phase 2
Austin, Texas, United States and 12 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
New Braunfels, Texas, United States and 76 other locations
ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...
Phase 3
Austin, Texas, United States and 48 other locations
doctor's choice of treatment in people with advanced or metastatic breast cancer. Advanced cancer is the one that is unlik...
Phase 2
Round Rock, Texas, United States and 132 other locations
growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...
Phase 3
Austin, Texas, United States and 292 other locations
endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...
Phase 3
New Braunfels, Texas, United States and 523 other locations
ribociclib or abemaciclib with letrozole) in people with breast cancer:* HR-positive (breast cancer cells that ne...
Phase 3
Round Rock, Texas, United States and 517 other locations
treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and arom...
Phase 3
Austin, Texas, United States and 234 other locations
ovarian function in premenopausal women with HR+, HER2-negative breast cancer. The study will also aim to assess the safety of TOL2 ...
Phase 3
Austin, Texas, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal